Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Therapeutics Enzymes Market Forecasts to 2028 – Global Analysis By Product Type (Chitinase, Asparginase and Other Product Types), By Application (Leukemia, Stomach Disorders and Other Applications), By End User (Drug manufacturers, Hospitals, Private clinics and Research laboratories) and Geography
... Research laboratories) and Geography According to Stratistics MRC, the Global Therapeutic Enzymes Market is accounted for $8467.9 million in 2022 and is expected to reach $18684.8 million by 2028 growing at a CAGR of 14.1% ... Read More
-
Investor Series: Opportunities in the AI-based Drug Discovery
... development process is the high attrition rate, which is often linked to the trial-and-error method adopted for lead identification. In this context, only a small percentage of pharmacological leads are eventually translated into potential candidates ... Read More
-
Brain Tumor Drugs Market Forecasts to 2028 - Global Analysis By Therapy (Targeted Therapy, Chemotherapy, Immunotherapy and Other Therapies), Indication (Pituitary Tumors, Meningioma, Glioblastoma and Glioma), Drugs (Bevacizumab, Temozolomide and Other Drugs) and Geography
... to Stratistics MRC, the Global Brain Tumor Drugs Market is accounted for $2.56 billion in 2022 and is expected to reach $4.80 billion by 2028 growing at a CAGR of 11.0% during the forecast period. ... Read More
-
Alzheimer's Therapeutics Market Report 2022-2032
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Large Number of Undiagnosed Patient Pool to Propel Growth Residents ... Read More
-
Hidradenitis Suppurativa (HS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... be more than three million diagnosed prevalent cases of HS across 16 pharmaceutical markets. T only one FDA-approved medication, Humira (adalimumab), available for the treatment of HS, which is used in severe cases only. A ... Read More
-
Digital Therapeutics Market Size By Component (Software, Device) By Application (Diabetes, Obesity, Cardiovascular, Mental & Behavioral Health, Hypertension, Insomnia) By Sales Channel (Business-to-business (B2B), Business-to-consumers (B2C)), Industry Analysis Report, Application Potential, Competitive Market Share & Forecast, 2023-2032
... Forecast, 2023-2032 Global Digital Therapeutics Market is slated to expand steadily through 2032 owing to the surging adoption of digital therapeutics in the healthcare sector and its potential to deliver better quality of care. Additionally, ... Read More
-
Retina Health Market Forecast till 2030
... the back of the eye that transforms light entering the eye into electrical signals that the brain may process into images. The prevention of vision problems and even blindness depends on a healthy retina. The ... Read More
-
Extensive Stage Small Cell Lung Cancer Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032
... small cell lung cancer is extremely aggressive sub-type of small cell lung cancer. Small cell lung itself is a sub-type of lung cancer which accounts for less than 20% cases. The treatment of extensive stage ... Read More
-
JEMPERLI (dostarlimab) Drug Insight and Market Forecast – 2032
... picture of the JEMPERLI (dostarlimab) for Metastatic Colorectal Cancer in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this ... Read More
-
KEYTRUDA (pembrolizumab) Drug Insight and Market Forecast – 2032
... picture of the KEYTRUDA (pembrolizumab) for Metastatic Colorectal Cancer in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this ... Read More
-
DNA Synthesis Market Size, Share & Trends Analysis Report By Service Type (Gene Synthesis, Oligonucleotide Synthesis), By Application (Research And Development, Therapeutics), By End-use, By Region, And Segment Forecasts, 2023 - 2030
... Growth & Trends The global DNA synthesis market size is expected to reach USD 12.76 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a ... Read More
-
Gastrointestinal Therapeutics Market Size, Share & Trends Analysis Report By Type, By Drug Class, By Application (Crohn’s Disease, Ulcerative Colitis, GERD), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 203
... 2030 Gastrointestinal Therapeutics Market Growth & Trends The global gastrointestinal therapeutics market size is expected to reach USD 48.61 billion by 2030, advancing at a CAGR of 3.3% during the forecast period, as per a ... Read More
-
mRNA Vaccines and Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... and therapeutics market showed significant growth in 2020 and 2021. The market under study continues to flourish with the detection of a new COVID-19 variant. The increase in demand for the development of new vaccines ... Read More
-
Global Alzheimer’s Therapeutics Market Size, Trends & Growth Opportunity, By Product (Cholinesterase Inhibitors, NMDA Receptor Antagonist, Combination Drug, Pipeline Drugs), By End-user (Hospital Pharmacy, Retail Pharmacy, E-commerce), Forecast till 2027.
... global Alzheimer’s Therapeutics Market was valued at USD 4.20 billion in 2021 which expected to reach USD 15.6 billion by 2027 at a CAGR 16.2% from 2020-2027 Qualiket Market Research covers topics such as worldwide ... Read More
-
India Urology Drugs Market, By Drug Class (Anticholinergic/ Antispasmodic Agents, Skeletal Muscle Relaxants, Alpha Blockers, Others), By Type (Original Drugs v/s Generic Drugs), By Application (Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Urinary
... Erectile Dysfunction, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online), By Region, Competition Forecast & Opportunities, FY2027 India urology drugs market is anticipated to grow with an estimated CAGR in the forecast years FY2023-FY2027, ... Read More
-
Global Antimalarial Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
... surge in research for new antimalarial drugs is anticipated to propel the growth of the market. According to the “World Malaria Report 2021” by World Health Organization (WHO), in 2020, there were approximately 228 million ... Read More
-
ANX005 Emerging Drug Insight and Market Forecast – 2032
... ANX005 for Huntington’s disease in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan, for the study period 2019–2032 is provided in this report along with a ... Read More
-
Dementia and Alzheimer’s Disease Treatment Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
... increasing cases of Alzheimer's and dementia coupled with growing awareness regarding the diseases are bolstering the growth of the market. Moreover, elderly population are more prone to such diseases due to growing age, which in ... Read More
-
Global Castrate Resistant Prostate Cancer Therapeutics Market Insights, Forecast to 2028
... Therapeutics estimated at US$ 15,175.51 million in the year 2022, is projected to reach a revised size of US$ 28,717.44 million by 2028, growing at a CAGR of 11.22% during the forecast period 2022-2028. The ... Read More
-
Attention Deficit Hyperactivity Disorder Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Stimulants, and Non-Stimulants); By Demographics; By Distribution Channel; By Region; Segment Forecast, 2023-2032
... is expected to reach USD 32.14 billion by 2032, according to a new study by Polaris Market Research. The report “Attention Deficit Hyperactivity Disorder Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Stimulants, ... Read More
-
Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) pipeline Target constitutes close to 9 molecules. Out of which approximately 4 molecules are developed by companies and remaining by ... Read More
-
Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Glycoprotein (RSV G or G) pipeline Target constitutes close to 5 molecules. Out of which approximately 5 molecules are developed by Companies. Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Respiratory syncytial virus ... Read More
-
Multiple Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Multiple Sclerosis (Central Nervous System) pipeline landscape. Multiple sclerosis (MS) is a potentially debilitating disease in which body's immune system eats away at the protective sheath (myelin) that covers nerves. ... Read More
-
Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... guide Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) - Drugs In Development, 2022, provides an overview of the Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) (Central Nervous System) pipeline ... Read More
-
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... III) (Sanfilippo Syndrome ) - Drugs In Development, 2022, provides an overview of the Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) (Genetic Disorders) pipeline landscape. Mucopolysaccharidosis type III (MPS III), also known as Sanfilippo syndrome, ... Read More
Research Assistance
